Literature DB >> 27581346

Protective Roles of Adipocytokines and Myokines in Cardiovascular Disease.

Noriyuki Ouchi1, Koji Ohashi, Rei Shibata, Toyoaki Murohara.   

Abstract

Obesity is a major risk factor for progression of cardiovascular disease. Adipose tissue is recognized as an endocrine organ producing various secretory molecules, also known as adipocytokines, and dysregulated production of adipocytokines participates in the pathogenesis of obesity complications, including metabolic dysfunction and cardiovascular disorders. Recent evidence indicates that skeletal muscle also functions as an endocrine organ capable of secreting a number of bioactive substances, also referred to as myokines. Several myokines are involved in metabolic and cardiovascular regulation. This review will discuss the clinical and experimental studies that have investigated the protective role of several adipocytokines and myokines in cardiovascular diseases. (Circ J 2016; 80: 2073-2080).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27581346     DOI: 10.1253/circj.CJ-16-0663

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  9 in total

1.  Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes.

Authors:  Corinna Niersmann; Maren Carstensen-Kirberg; Haifa Maalmi; Bernd Holleczek; Michael Roden; Hermann Brenner; Christian Herder; Ben Schöttker
Journal:  Diabetologia       Date:  2019-11-09       Impact factor: 10.122

Review 2.  Measuring myokines with cardiovascular functions: pre-analytical variables affecting the analytical output.

Authors:  Giovanni Lombardi; Veronica Sansoni; Giuseppe Banfi
Journal:  Ann Transl Med       Date:  2017-08

Review 3.  Mechanisms by Which Skeletal Muscle Myokines Ameliorate Insulin Resistance.

Authors:  Rekha Balakrishnan; Debbie C Thurmond
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

4.  Association of handgrip strength with the prevalence of metabolic syndrome in US adults: the national health and nutrition examination survey.

Authors:  Chao Ji; Yang Xia; Shuhui Tong; Qijun Wu; Yuhong Zhao
Journal:  Aging (Albany NY)       Date:  2020-05-04       Impact factor: 5.682

5.  Physiological Responses to Swimming-Induced Exercise in the Adult Zebrafish Regenerating Heart.

Authors:  Mireia Rovira; Daniel M Borràs; Inês J Marques; Carolina Puig; Josep V Planas
Journal:  Front Physiol       Date:  2018-10-01       Impact factor: 4.566

6.  Associations among circulating levels of follistatin-like 1, clinical parameters, and cardiovascular events in patients undergoing elective percutaneous coronary intervention with drug-eluting stents.

Authors:  Tatsuro Aikawa; Kazunori Shimada; Katsumi Miyauchi; Tetsuro Miyazaki; Eiryu Sai; Shohei Ouchi; Tomoyasu Kadoguchi; Mitsuhiro Kunimoto; Yusuke Joki; Tomotaka Dohi; Shinya Okazaki; Kikuo Isoda; Koji Ohashi; Toyoaki Murohara; Noriyuki Ouchi; Hiroyuki Daida
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

Review 7.  Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications.

Authors:  Sandra Maria Barbalho; Uri Adrian Prync Flato; Ricardo José Tofano; Ricardo de Alvares Goulart; Elen Landgraf Guiguer; Cláudia Rucco P Detregiachi; Daniela Vieira Buchaim; Adriano Cressoni Araújo; Rogério Leone Buchaim; Fábio Tadeu Rodrigues Reina; Piero Biteli; Daniela O B Rodrigues Reina; Marcelo Dib Bechara
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

8.  Prognostic value of cardio-hepatic-skeletal muscle syndrome in patients with heart failure.

Authors:  Takumi Noda; Kentaro Kamiya; Nobuaki Hamazaki; Kohei Nozaki; Takafumi Ichikawa; Takeshi Nakamura; Masashi Yamashita; Shota Uchida; Emi Maekawa; Jennifer L Reed; Minako Yamaoka-Tojo; Atsuhiko Matsunaga; Junya Ako
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

Review 9.  The cardiosplenic axis: the prognostic role of the spleen in heart failure.

Authors:  Hiroaki Hiraiwa; Takahiro Okumura; Toyoaki Murohara
Journal:  Heart Fail Rev       Date:  2022-05-18       Impact factor: 4.654

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.